DOR-1 (phospho Ser363) Polyclonal Antibody

Rabbit Anti-DOR-1 (phospho Ser363) Polyclonal Antibody

Product Specifications

Background

OPRD1 (Opioid Receptor Delta 1) is a Protein Coding gene. Diseases associated with OPRD1 include morphine dependence and heroin dependence. Among its related pathways are cGMP-PKG signaling pathway andPeptide ligand-binding receptors. GO annotations related to this gene include G-protein coupled receptor activity and opioid receptor activity. An important paralog of this gene is GALR2.

CAS Number

9007-83-4

Product Name Alternative

OPRD1; OPRD; Delta-type opioid receptor; D-OR-1; DOR-1

Gene ID

4985

Accession Number

P41143

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from human DOR-1 around the phosphorylation site of S363

Clonality

Polyclonal

Tag

Delta-type opioid receptor

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

36kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

Phospho-DOR-1 (S363) Polyclonal Antibody detects endogenous levels of DOR-1 protein only when phosphorylated at S363.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:5000; IF 1:50-200